Lysosomal storage diseases: current therapies and future alternatives

Area of Science:

• Biochemistry
• Genetics
• Molecular Biology

Background:

• Lysosomal storage disorders (LSDs) are inherited conditions resulting from genetic mutations.
• These mutations cause the buildup of undegraded substances within lysosomes, impairing cellular function.
• Current treatments for LSDs include enzyme replacement, substrate reduction, and stem cell transplantation.

Purpose of the Study:

• To review existing therapeutic strategies for lysosomal storage disorders.
• To detail advancements in genome editing technologies for LSD treatment.
• To discuss the challenges and ethical debates surrounding genome editing applications.

Main Methods:

• Literature review of current LSD therapies.
• Analysis of major genome editing technologies (e.g., CRISPR-Cas9).
• Examination of recent research on gene therapy for LSDs.

Main Results:

• Genome editing presents a novel approach to address the genetic basis of LSDs.
• Significant progress has been made in applying gene editing tools to develop potential LSD treatments.
• Various genome editing techniques show promise for correcting the underlying genetic defects in LSDs.

Conclusions:

• Genome editing holds substantial potential for developing innovative and effective therapies for LSDs.
• Further research and ethical considerations are crucial for the clinical translation of these technologies.
• Gene therapy, particularly using genome editing, represents a rapidly evolving frontier in LSD treatment.